Evidence map›Paper›PMID 35206404›Full record

SynthesisInternational journal of environmental research and public health2022

Prevalence of Coronavirus Disease 2019 (COVID-19) in Different Clinical Stages before the National COVID-19 Vaccination Programme in Malaysia: A Systematic Review and Meta-Analysis.

Jun Wei Ng, Eric Tzyy Jiann Chong, Yee Ann Tan, Heng Gee Lee, Lan Lan Chan, Qin Zhi Lee, Yen Tsen Saw, Yiko Wong, Ahmad Aizudeen Bin Zakaria, Zarina Binti Amin and 1 more

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. COVID-19 Treatment-Current Status, Advances, and Gap.Pathogens (Basel, Switzerland) · 2022
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jun Wei NgBiotechnology Programme, Faculty of Science and Natural Resources, Universiti Malaysia Sabah, Jalan UMS, Kota Kinabalu 88400, Sabah, Malaysia.
Eric Tzyy Jiann ChongBiotechnology Programme, Faculty of Science and Natural Resources, Universiti Malaysia Sabah, Jalan UMS, Kota Kinabalu 88400, Sabah, Malaysia.ORCID 0000-0003-0452-6547
Yee Ann TanQueen Elizabeth Hospital, Jalan Penampang, Kota Kinabalu 88200, Sabah, Malaysia.
Heng Gee LeeQueen Elizabeth Hospital, Jalan Penampang, Kota Kinabalu 88200, Sabah, Malaysia.
Lan Lan ChanQueen Elizabeth Hospital, Jalan Penampang, Kota Kinabalu 88200, Sabah, Malaysia.
Qin Zhi LeeQueen Elizabeth Hospital, Jalan Penampang, Kota Kinabalu 88200, Sabah, Malaysia.ORCID 0000-0002-3903-4553
Yen Tsen SawQueen Elizabeth Hospital, Jalan Penampang, Kota Kinabalu 88200, Sabah, Malaysia.
Yiko WongQueen Elizabeth Hospital, Jalan Penampang, Kota Kinabalu 88200, Sabah, Malaysia.
Ahmad Aizudeen Bin ZakariaQueen Elizabeth Hospital, Jalan Penampang, Kota Kinabalu 88200, Sabah, Malaysia.
Zarina Binti AminBiotechnology Research Institute, Universiti Malaysia Sabah, Jalan UMS, Kota Kinabalu 88400, Sabah, Malaysia.
Ping-Chin LeeBiotechnology Programme, Faculty of Science and Natural Resources, Universiti Malaysia Sabah, Jalan UMS, Kota Kinabalu 88400, Sabah, Malaysia.ORCID 0000-0002-4280-0829

Funding

Universiti of Malaysia Sabah DKC2002
6 · The paper itself

Abstract

More than 1.75 million COVID-19 infections and 16 thousand associated deaths have been reported in Malaysia. A meta-analysis on the prevalence of COVID-19 in different clinical stages before the National COVID-19 Vaccination Program in Malaysia is still lacking. To address this, the disease severity of a total of 215 admitted COVID-19 patients was initially recorded in the early phase of this study, and the data were later pooled into a meta-analysis with the aim of providing insight into the prevalence of COVID-19 in 5 different clinical stages during the outset of the COVID-19 pandemic in Malaysia. We have conducted a systematic literature search using PubMed, Web of Science, Scopus, ScienceDirect, and two preprint databases (bioRxiv and medRxiv) for relevant studies with specified inclusion and exclusion criteria. The quality assessment for the included studies was performed using the Newcastle-Ottawa Scale. The heterogeneity was examined with an I

Indexed as

COVID-19COVID-19 VaccinesHumansMalaysiaPandemicsPrevalenceSARS-CoV-2VaccinationCOVID-19 Vaccinesclinical stagesCOVID-19 prevalenceMalaysiameta-analysisvaccination program

Identifiers

PMID35206404
PMCPMC8871879

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.